Successful parathyroid tissue autograft after 3 years of cryopreservation: a case report
Carregando...
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
Citação
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, v.58, n.3, p.313-316, 2014
Resumo
After a total parathyroidectomy, well-established protocols for the cryopreservation of parathyroid tissue and for the delayed autograft of this tissue exist, especially in cases of secondary hiperparathyroidism (HPT) or familial or sporadic parathyroid hyperplasia. Although delayed autografts are effective, the published success rates vary from 10% to 83%. There are numerous factors that influence the viability, and therefore the success, of an autograft, including cryopreservation time. Certain authors believe that the tissue is only viable for 24 months, but there is no consensus on how long the parathyroid tissue can be preserved. A 63-year-old male who was diagnosed with sporadic multiple endocrine neoplasia type 1 and primary hyperparathyroidism, and was submitted to a total parathyroidectomy and an autograft in the forearm. The implant failed, and the patient developed severe hypoparathyroidism in the months following the surgery. Thirty-six months after the total parathyroidectomy, the cryopreserved autograft was successfully transplanted, and hypoparathyroidism was reversed (most recent systemic parathyroid hormone, PTH, of 36 pg/mL, and total calcium of 9.1 mg/dL; no oral calcium supplementation). The case presented here indicates that cryopreserved parathyroid tissue may remain viable after 24 months in storage, and may retain the capacity to reverse permanent postsurgical hypoparathyroidism. These data provide reasonable evidence that the time limit for cryopreservation remains undetermined and that additional research would be valuable.
Palavras-chave
Referências
- Barreira CESR, 2011, WORLD J SURG, V35, P2440, DOI 10.1007/s00268-011-1261-x
- Borot S, 2010, SURGERY, V147, P529, DOI 10.1016/j.surg.2009.10.010
- Caccitolo JA, 1997, SURGERY, V122, P1062, DOI 10.1016/S0039-6060(97)90209-9
- Coutinho FL, 2010, CLIN ENDOCRINOL, V72, P462, DOI 10.1111/j.1365-2265.2009.03672.x
- d'Alessandro AF, 2012, REV ASSOC MED BRAS, V58, P323, DOI 10.1590/S0104-42302012000300012
- Montenegro FLD, 2007, HEAD NECK-J SCI SPEC, V29, P296, DOI 10.1002/hed.20506
- Feldman AL, 1999, SURGERY, V126, P1042, DOI 10.1067/msy.2099.101580
- Guerrero MA, 2008, WORLD J SURG, V32, P836, DOI 10.1007/s00268-007-9437-0
- HERRERA M, 1992, ARCH SURG-CHICAGO, V127, P825
- Herrera M, 1992, ARCH SURG-CHICAGO, V127, P9
- Lourenco DM, 2010, J BONE MINER RES, V25, P2382, DOI 10.1002/jbmr.125
- McHenry CR, 1997, AM J SURG, V174, P481, DOI 10.1016/S0002-9610(97)00156-6
- Montenegro FLD, 2012, CLINICS, V67, P131, DOI 10.6061/clinics/2012(Sup01)22
- ROTHMUND M, 1984, WORLD J SURG, V8, P527
- Schneider R, 2012, WORLD J SURG, V36, P2598, DOI 10.1007/s00268-012-1730-x
- Smeds S, 1999, APMIS, V107, P445
- Ulrich F, 2001, TRANSPLANT P, V33, P666, DOI 10.1016/S0041-1345(00)02192-8
- WAGNER PK, 1991, WORLD J SURG, V15, P751
- WAGNER PK, 1986, SURGERY, V99, P257
- WELLS SA, 1974, SURGERY, V75, P49
- WELLS SA, 1977, SURGERY, V81, P86